CHF Solutions Inc. (CHFS)
Symbol Info
Listed Symbol CHFS
Name CHF Solutions Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $4,998,000
Latest Fiscal EPS $-44.23
Price Info
21 Day Moving Average $2.5439
21 Day EMA $2.540360
50 Day Moving Average $2.6311
50 Day EMA $2.700370
200 Day EMA $8.286180
200 Day Moving Average 5.196860
52 Week High $18.90
52 Week Low $2.05
52 Week Change $-86.093600
Alpha -0.127811
Beta 2.3051
Standard Deviation 0.290797
R2 0.074666
Periods 60
Share Information
10 Day Average Volume 161,618
20 Day Average Volume 116,082
30 Day Average Volume 103,920
50 Day Average Volume 108,629
Outstanding Shares 2,584,972
Float Shares 273,069
Percent Float 10.56%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 16
Institute Holdings Date 2019-08-31
Institute Bought Previous 3 Months 68,827
Institute Holdings Percent 18.900000
Institute Sold Previous 3 Months 1,287
Insider Holdings Date 2019-03-31
Insider Bought Previous 3 Months 9,523
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 2,311,903
Price Change
7 Day Price Change $-0.5
7 Day Percent Change -18.52%
21 Day Price Change $-0.3399999
21 Day Percent Change -13.39%
30 Day Price Change $-0.24
30 Day Percent Change -9.84%
Month To Date Price Change $-0.37
Month To Date Percent -14.40%
90 Day Price Change $-0.97
90 Day Percent Change -30.60%
Quarter To Date $-0.71
Quarter To Date Percent -24.40%
180 Day Price Change $-1.35
180 Day Percent Change -38.03%
200 Day Price Change $-6.855001
200 Day Percent Change -75.70%
Year To Date $-4.6348
Year To Date Percent -67.81%
Profile
Description CHF Solutions Inc is an early-stage medical device company based in the US. It focuses on commercializing the Aquadex FlexFlow System. The Aquadex FlexFlow System is used for temporary and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It is designed to remove excess fluid ( primarily excess salt and water) from patients suffering from fluid overload who have failed diuretic therapy. The company operates through a single segment being Cardiac and coronary disease products.
Details
Issue Type CS
Market Cap $5,686,938
Sec Type EQS
Auditor Baker Tilly Virchow Krause, LLP
Total Shares Outstanding 2,584,972
CEO John L. Erb
Employees 55
Last Audit UE
Classification
CIK 0001506492
Industry Medical Devices
Sector Healthcare
NAICS Irradiation Apparatus Manufacturing(334517)
Info
Address 12988 Valley View Road
Eden Prairie, MN 55344
Website https://www.chf-solutions.com
Facisimile
Telephone +1 952 345-4200
Email IR@sunshineheart.com
Key Ratios
Profitability
EBIT Margin -306.8
EBITDA Margin -302.7
Pre-Tax Profit Margin -11,194.1
Profit Margin Cont -
Gross Margin 41.80
Profit Margin TOT -
Income Statements
Revenue $5,754,000
Revenue Per Share $2.2259
Revenue 3 Years $-
Revenue 5 Years $127.15
Valuation Measures
PE Ratio -
Enterprise Value $-1,207,912
Price To Sales 0.988345
Price To Free Cash -0.4
PE High Last 5 Years -
Price To Book 0.7
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 0.7
Financial Strength
Total Debt To Equity 0.1
Int Coverage -
Current Ratio 3.9
Leverage Ratio 1.3
Quick Ratio 3.2
Long Term Debt To Capital 0.04
Assets
Receivables Turnover 3.2
Invoice Turnover 1.70
Assets Turnover 0.20
Management Effectiveness
Return Assets -198.18
Return On Equity -257.07
Return On Capital -242.1
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
CHFS
CHF Soluti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.